查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1494621

個人化醫療市場：按產品、應用和最終用戶分類 - 全球預測 2024-2030

Personalized Medicine Market by Product (Personalized Medical Care, Personalized Medicine Diagnostics, Personalized Medicine Therapeutics), Application (Antiviral, Cardiology, Immunology), End Users - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計2023年個人化醫療市場規模為5,421億美元，預計2024年將達5,755億美元，2030年將達8,520.2億美元，複合年成長率為6.67%。

個人化醫療是客製化的醫療保健，根據個別患者的情況（包括遺傳、分子、環境和生活方式因素）量身訂做治療方案。這種適應性醫學充分利用基因組學、即時診斷等關鍵技術，涵蓋診斷、治療、個體化醫療、個人化營養指導等廣泛應用。該市場的成長歸因於人工智慧等技術進步以及由於全球個人慢性病盛行率不斷上升而需要個人化健康干預措施。然而，研究和基礎設施開發的高額初始投資，以及與使用個人化醫療相關的隱私問題，可能會阻礙市場成長。人工智慧、行動醫療技術和再生醫學提供了大量可以改變治療模式的創新機會。此外，全球健康資料整合的增加以及公眾和專業人士參與的增加可能會進一步促進個人化醫療解決方案的廣泛採用。

主要市場統計
基準年[2023] 5421億美元
預測年份 [2024] 5755億美元
預測年份 [2030] 8520.2億美元
複合年成長率（%） 6.67%

區域洞察

在北美，政府和私營部門的大量投資正在推動市場發展，在腫瘤學和心臟病學等領域明顯傾向於個人化醫療。該地區強調將個人化醫療納入公共衛生保健系統。在南美洲，特別是在巴西、阿根廷和智利，基因檢測的普及使得預防醫學和量身定做的治療策略成為可能。當地研究機構和全球研究公司之間合作的增加也補充了這種成長。在歐盟委員會的支持以及與個人化醫療相關的倫理和法律的大力關注下，歐盟 (EU) 對個人化醫療研究表現出越來越濃厚的興趣。中東和非洲在這一領域正在興起，以色列和沙烏地阿拉伯在發展個體化醫療方面取得了長足進步，各國政府專注於醫療改革和教育。南非正在利用其獨特的遺傳多樣性為世界其他地區開拓基因組醫學計劃。亞太地區在透過個人化醫療策略利用技術力來解決遺傳疾病和癌症負擔沉重的老齡化人口方面正在取得快速進展。該地區的消費者越來越願意參與基因檢測和個人化醫療保健計劃。政府策略性舉措著重於基因組學和個人化醫療解決方案，以解決遺傳疾病和各種癌症的高盛行率。

FPNV定位矩陣

FPNV 定位矩陣對於評估供應商在個人化醫療市場的定位至關重要。此矩陣提供了對供應商的全面評估，並檢查了與業務策略和產品滿意度相關的關鍵指標。這種詳細的評估使用戶能夠根據自己的要求做出明智的決定。根據評估結果，供應商被分為代表其成功程度的四個像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市場佔有率分析

市場佔有率分析是一種綜合工具，可以對個人化醫療市場中供應商的現狀進行深入而詳細的評估。透過仔細比較和分析供應商的貢獻，您可以更深入地了解每個供應商的績效以及他們在爭奪市場佔有率時面臨的挑戰。這些貢獻包括整體收益、客戶群和其他重要指標。此外，該分析還提供了對該行業競爭力的寶貴見解，包括研究基準年期間觀察到的累積、分散主導地位和合併特徵等因素。有了這些詳細資訊，供應商可以做出更明智的決策並製定有效的策略，以在市場競爭中保持領先地位。

策略分析與建議

策略分析對於尋求在全球市場站穩腳跟的組織至關重要。對目前在個人化醫療市場中的地位進行全面評估，使公司能夠做出符合其長期願望的明智決策。這項關鍵評估涉及對組織的資源、能力和整體績效的徹底分析，以確定核心優勢和需要改進的領域。

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 加強生物技術研究力度並提高對遺傳學的了解
      • 快速採用針對複雜疾病的個人化醫療策略
      • 政府支持活動，以提高對個人化醫療的認知和獲取
    • 抑制因素
      • 實施個人化醫療的複雜性和缺乏熟練人員
    • 機會
      • 持續的研發活動以改善個人化醫療
      • 採用虛擬和數位策略進行個人化醫療的可能性
    • 任務
      • 可訪問性限制和準確性問題
  • 市場區隔分析
    • 依產品：個人化營養和健康的引入正在提高人們對身體健康和心理健康的認知。
    • 依應用分類：由於需要精準治療，個人化醫療在神經學的應用越來越多
  • 市場擾動分析
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 價格分析
  • 技術分析
  • 專利分析
  • 貿易分析
  • 法規結構分析

第6章個人化醫療市場：依產品

  • 個人化醫療護理
  • 個性化醫療診斷
  • 個人化醫療
  • 個人化營養與健康

第7章個人化醫療市場：依應用分類

  • 抗病毒藥
  • 心臟病學
  • 免疫學
  • 神經病學
  • 腫瘤學
  • 精神病學

第8章個人化醫療市場：依最終用戶分類

  • 學術研究機構與實驗室
  • 生物/健康資訊學公司
  • 受託研究機構
  • 診斷公司和檢測機構
  • 醫院和臨床護理

第9章美洲個人化醫療市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太個人化醫療市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章 歐洲、中東和非洲個人化醫療市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 市場佔有率分析（2023）
  • FPNV定位矩陣（2023）
  • 競爭情境分析
    • 阿斯特捷利康收購 Fusion Pharmaceuticals 開發個人化癌症藥物
    • CurifyLabs 從 Mehta Heino Industries 收購關鍵 3D 列印 IP，以推進個人化醫療解決方案
    • 策略性收購增強諾華精準醫療能力
  • 戰略分析和建議

第13章競爭產品組合

  • 主要企業簡介
  • 主要產品系列
Product Code: MRR-4D00F1312F65

[183 Pages Report] The Personalized Medicine Market size was estimated at USD 542.10 billion in 2023 and expected to reach USD 575.50 billion in 2024, at a CAGR 6.67% to reach USD 852.02 billion by 2030.

Personalized medicine is customized healthcare that aligns medical treatments with individual patient profiles, which include genetic, molecular, environmental, and lifestyle factors. This adaptive practice spans diverse applications, including diagnostics, therapeutics, tailored medical care, and customized nutritional guidance, using key technologies such as genomics and real-time diagnostics. Growth in this market is due to advancements in technology, such as AI, and the necessity of personalized health interventions due to the increasing prevalence of chronic disease rates among individuals around the globe. However, high initial cost investment for research and infrastructure and privacy concerns associated with the use of personalized medicine use can hinder market growth. Opportunities for innovation abound in AI, mobile health technologies, and regenerative medicine, which can shift therapeutic paradigms. Additionally, the push towards global health data integration and heightened public and professional engagement can further encourage the broad adoption of personalized health solutions.

KEY MARKET STATISTICS
Base Year [2023] USD 542.10 billion
Estimated Year [2024] USD 575.50 billion
Forecast Year [2030] USD 852.02 billion
CAGR (%) 6.67%

Regional Insights

In North America, the market is propelled by substantial investments from both government and private sectors, with a clear inclination towards personalized treatments observed in fields such as oncology and cardiology. The region emphasizes the integration of personalized medicine into public healthcare systems. In South America, mainly Brazil, Argentina, and Chile, the surge in genetic testing enabled preventative care and tailored treatment strategies. This growth is complemented by increasing collaborations between local research entities and global research firms. European Union showed a growing interest in personalized medical research, with backing from the European Commission and an acute focus on the ethical and legal dimensions associated with personalized medicine. The Middle East and Africa are emerging in this arena, with Israel and Saudi Arabia making significant strides in the development of customized medicine by increasing governmental focus on healthcare reform and education. South Africa is leveraging its unique genetic diversity to pioneer genomic medicine projects for the rest of the world with active investment for global organizations in healthcare and research. The Asia Pacific region showcases rapid progress with technological prowess to cater to its aging population through personalized healthcare strategies for its high burden of genetic diseases and cancer. The region is showing increased consumer readiness to participate in genetic testing and personalized healthcare programs. The government's strategic initiatives emphatically support genomics and personalized treatment solutions in response to the high prevalence of genetic diseases and various cancers within the population.

Market Insights

  • Market Dynamics

The market dynamics represent an ever-changing landscape of the Personalized Medicine Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

    • Market Drivers
      • Rise in biotechnology research initiatives and improved understanding of genetics
      • Surge in the adoption of personalized treatment strategies for targeting complex diseases
      • Supportive government initiatives to raise awareness for and access to personalized medicine
    • Market Restraints
      • Complexities in the implementation of personalized medicine and lack of skilled personnel
    • Market Opportunities
      • Ongoing R&D activities for improvements in personalized medicines
      • Potential for the adoption of virtual and digital strategies for personalized medicine
    • Market Challenges
      • Limited accessibility and issues related to accuracy
  • Market Segmentation Analysis
    • Product: Growing awareness about physical health and mental health owing to the adoption of personalized nutrition & wellness
    • Application: Increased adoption of personalized medicine in neurology due to the need for precise treatment
  • Market Disruption Analysis
  • Porter's Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Personalized Medicine Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Personalized Medicine Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

AstraZeneca Acquires Fusion Pharmaceuticals for Personalized Cancer Medicine

AstraZeneca acquired Fusion Pharmaceuticals, a biopharmaceutical company specializing in next-generation radioconjugates, in a deal potentially worth up to USD 2400 million. This acquisition represents a pivotal development in the cancer treatment landscape, with Fusion enhancing AstraZeneca's capacity to deliver innovative, patient-specific therapies. [Published On: 2024-03-19]

CurifyLabs Acquires Key 3D Printing IP from Mehta Heino Industries to Advance Personalized Medicine Solutions

CurifyLabs, a health technology company, acquired significant intellectual property from Mehta Heino Industries Oy. This acquisition aims to enhance CurifyLabs' capabilities in producing personalized medicines for hospitals and compounding pharmacies, focusing particularly on pediatric populations. This acquisition is pivotal for pioneering new frontiers in personalized medicine and fortifying the company's expertise in 3D printing and advanced robotics. [Published On: 2024-01-17]

Strategic Acquisition Enhances Novartis' Precision Medicine Capabilities

Novartis successfully acquired Chinook Therapeutics, a company specializing in precision medicines. This move aligns with Novartis' strategic objective to broaden its portfolio in the precision medicine sector, particularly in developing advanced treatments for kidney diseases. The integration of Chinook's expertise is anticipated to strengthen Novartis' position in the market, facilitating better-targeted and more effective healthcare solutions. [Published On: 2023-08-14]

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Personalized Medicine Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Personalized Medicine Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Amgen, Inc., AstraZeneca, Bayer Ag, BIOGEN INC., Eli Lilly and Company, Exact Sciences Corporation, Exagen Inc, F. Hoffmann-La Roche Ltd, GE HealthCare Technologies Inc., Glaxosmithkline Plc., Illumina, Inc., Johnson & Johnson Services, Inc., Laboratory Corporation of America Holdings, Merck & Co., Inc., Novartis International AG, Pfizer Inc., Precision Biologics, Inc., QIAGEN GmbH, and Takeda Pharmaceutical Company Limited.

Market Segmentation & Coverage

This research report categorizes the Personalized Medicine Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • Personalized Medical Care
      • Health Information Technology
      • Telemedicine
    • Personalized Medicine Diagnostics
      • Direct-to-consumer (DTC) Diagnostics
      • Esoteric Lab Services
      • Esoteric Lab Tests
      • Genetic Testing
    • Personalized Medicine Therapeutics
      • Genomic Medicine
      • Medical Devices
      • Pharmaceutical
    • Personalized Nutrition & Wellness
      • Complementary & Alternative Medicine
      • Retail Nutrition
  • Application
    • Antiviral
    • Cardiology
    • Immunology
    • Neurology
    • Oncology
    • Psychiatry
  • End Users
    • Academic Research Institutes & Research Laboratories
    • Bio & Health Informatics Companies
    • Contract Research Organizations
    • Diagnostic Companies & Testing Facilities
    • Hospitals & Clinical Care
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rise in biotechnology research initiatives and improved understanding of genetics
      • 5.1.1.2. Surge in the adoption of personalized treatment strategies for targeting complex diseases
      • 5.1.1.3. Supportive government initiatives to raise awareness for and access to personalized medicine
    • 5.1.2. Restraints
      • 5.1.2.1. Complexities in the implementation of personalized medicine and lack of skilled personnel
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing R&D activities for improvements in personalized medicines
      • 5.1.3.2. Potential for the adoption of virtual and digital strategies for personalized medicine
    • 5.1.4. Challenges
      • 5.1.4.1. Limited accessibility and issues related to accuracy
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Growing awareness about physical health and mental health owing to the adoption of personalized nutrition & wellness
    • 5.2.2. Application: Increased adoption of personalized medicine in neurology due to the need for precise treatment
  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. Personalized Medicine Market, by Product

  • 6.1. Introduction
  • 6.2. Personalized Medical Care
  • 6.3. Personalized Medicine Diagnostics
  • 6.4. Personalized Medicine Therapeutics
  • 6.5. Personalized Nutrition & Wellness

7. Personalized Medicine Market, by Application

  • 7.1. Introduction
  • 7.2. Antiviral
  • 7.3. Cardiology
  • 7.4. Immunology
  • 7.5. Neurology
  • 7.6. Oncology
  • 7.7. Psychiatry

8. Personalized Medicine Market, by End Users

  • 8.1. Introduction
  • 8.2. Academic Research Institutes & Research Laboratories
  • 8.3. Bio & Health Informatics Companies
  • 8.4. Contract Research Organizations
  • 8.5. Diagnostic Companies & Testing Facilities
  • 8.6. Hospitals & Clinical Care

9. Americas Personalized Medicine Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Personalized Medicine Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Personalized Medicine Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. AstraZeneca Acquires Fusion Pharmaceuticals for Personalized Cancer Medicine
    • 12.3.2. CurifyLabs Acquires Key 3D Printing IP from Mehta Heino Industries to Advance Personalized Medicine Solutions
    • 12.3.3. Strategic Acquisition Enhances Novartis' Precision Medicine Capabilities
  • 12.4. Strategy Analysis & Recommendation

13. Competitive Portfolio

  • 13.1. Key Company Profiles
  • 13.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. PERSONALIZED MEDICINE MARKET RESEARCH PROCESS
  • FIGURE 2. PERSONALIZED MEDICINE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. PERSONALIZED MEDICINE MARKET DYNAMICS
  • FIGURE 7. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS PERSONALIZED MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 14. AMERICAS PERSONALIZED MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES PERSONALIZED MEDICINE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 16. UNITED STATES PERSONALIZED MEDICINE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC PERSONALIZED MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC PERSONALIZED MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA PERSONALIZED MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA PERSONALIZED MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. PERSONALIZED MEDICINE MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 22. PERSONALIZED MEDICINE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. PERSONALIZED MEDICINE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY HEALTH INFORMATION TECHNOLOGY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY HEALTH INFORMATION TECHNOLOGY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY TELEMEDICINE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY TELEMEDICINE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY DIRECT-TO-CONSUMER (DTC) DIAGNOSTICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY DIRECT-TO-CONSUMER (DTC) DIAGNOSTICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY ESOTERIC LAB SERVICES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY ESOTERIC LAB SERVICES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY ESOTERIC LAB TESTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY ESOTERIC LAB TESTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY GENETIC TESTING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY GENETIC TESTING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY GENOMIC MEDICINE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY GENOMIC MEDICINE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY MEDICAL DEVICES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY MEDICAL DEVICES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY PHARMACEUTICAL, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY PHARMACEUTICAL, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 39. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 40. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 41. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2023 (USD MILLION)
  • TABLE 42. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2024-2030 (USD MILLION)
  • TABLE 43. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY COMPLEMENTARY & ALTERNATIVE MEDICINE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 44. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY COMPLEMENTARY & ALTERNATIVE MEDICINE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 45. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY RETAIL NUTRITION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 46. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY RETAIL NUTRITION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 47. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 48. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 49. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY ANTIVIRAL, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 50. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY ANTIVIRAL, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 51. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 52. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY CARDIOLOGY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 53. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 54. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 55. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 56. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY NEUROLOGY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 57. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 58. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY ONCOLOGY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 59. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY PSYCHIATRY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 60. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY PSYCHIATRY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 61. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 62. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 63. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES & RESEARCH LABORATORIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 64. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES & RESEARCH LABORATORIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 65. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY BIO & HEALTH INFORMATICS COMPANIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 66. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY BIO & HEALTH INFORMATICS COMPANIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 67. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 68. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 69. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY DIAGNOSTIC COMPANIES & TESTING FACILITIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 70. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY DIAGNOSTIC COMPANIES & TESTING FACILITIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 71. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY HOSPITALS & CLINICAL CARE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 72. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY HOSPITALS & CLINICAL CARE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 73. AMERICAS PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 74. AMERICAS PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 75. AMERICAS PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2023 (USD MILLION)
  • TABLE 76. AMERICAS PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2024-2030 (USD MILLION)
  • TABLE 77. AMERICAS PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 78. AMERICAS PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 79. AMERICAS PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2023 (USD MILLION)
  • TABLE 80. AMERICAS PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2024-2030 (USD MILLION)
  • TABLE 81. AMERICAS PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2023 (USD MILLION)
  • TABLE 82. AMERICAS PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2024-2030 (USD MILLION)
  • TABLE 83. AMERICAS PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 84. AMERICAS PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 85. AMERICAS PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 86. AMERICAS PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 87. AMERICAS PERSONALIZED MEDICINE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 88. AMERICAS PERSONALIZED MEDICINE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 89. ARGENTINA PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 90. ARGENTINA PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 91. ARGENTINA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2023 (USD MILLION)
  • TABLE 92. ARGENTINA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2024-2030 (USD MILLION)
  • TABLE 93. ARGENTINA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 94. ARGENTINA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 95. ARGENTINA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2023 (USD MILLION)
  • TABLE 96. ARGENTINA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2024-2030 (USD MILLION)
  • TABLE 97. ARGENTINA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2023 (USD MILLION)
  • TABLE 98. ARGENTINA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2024-2030 (USD MILLION)
  • TABLE 99. ARGENTINA PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 100. ARGENTINA PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 101. ARGENTINA PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 102. ARGENTINA PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 103. BRAZIL PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 104. BRAZIL PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 105. BRAZIL PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2023 (USD MILLION)
  • TABLE 106. BRAZIL PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2024-2030 (USD MILLION)
  • TABLE 107. BRAZIL PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 108. BRAZIL PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 109. BRAZIL PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2023 (USD MILLION)
  • TABLE 110. BRAZIL PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2024-2030 (USD MILLION)
  • TABLE 111. BRAZIL PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2023 (USD MILLION)
  • TABLE 112. BRAZIL PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2024-2030 (USD MILLION)
  • TABLE 113. BRAZIL PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 114. BRAZIL PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 115. BRAZIL PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 116. BRAZIL PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 117. CANADA PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 118. CANADA PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 119. CANADA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2023 (USD MILLION)
  • TABLE 120. CANADA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2024-2030 (USD MILLION)
  • TABLE 121. CANADA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 122. CANADA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 123. CANADA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2023 (USD MILLION)
  • TABLE 124. CANADA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2024-2030 (USD MILLION)
  • TABLE 125. CANADA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2023 (USD MILLION)
  • TABLE 126. CANADA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2024-2030 (USD MILLION)
  • TABLE 127. CANADA PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 128. CANADA PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 129. CANADA PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 130. CANADA PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 131. MEXICO PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 132. MEXICO PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 133. MEXICO PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2023 (USD MILLION)
  • TABLE 134. MEXICO PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2024-2030 (USD MILLION)
  • TABLE 135. MEXICO PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 136. MEXICO PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 137. MEXICO PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2023 (USD MILLION)
  • TABLE 138. MEXICO PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2024-2030 (USD MILLION)
  • TABLE 139. MEXICO PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2023 (USD MILLION)
  • TABLE 140. MEXICO PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2024-2030 (USD MILLION)
  • TABLE 141. MEXICO PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 142. MEXICO PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 143. MEXICO PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 144. MEXICO PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 145. UNITED STATES PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 146. UNITED STATES PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 147. UNITED STATES PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2023 (USD MILLION)
  • TABLE 148. UNITED STATES PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2024-2030 (USD MILLION)
  • TABLE 149. UNITED STATES PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 150. UNITED STATES PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 151. UNITED STATES PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2023 (USD MILLION)
  • TABLE 152. UNITED STATES PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2024-2030 (USD MILLION)
  • TABLE 153. UNITED STATES PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2023 (USD MILLION)
  • TABLE 154. UNITED STATES PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2024-2030 (USD MILLION)
  • TABLE 155. UNITED STATES PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 156. UNITED STATES PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 157. UNITED STATES PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 158. UNITED STATES PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 159. UNITED STATES PERSONALIZED MEDICINE MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 160. UNITED STATES PERSONALIZED MEDICINE MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 161. ASIA-PACIFIC PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 162. ASIA-PACIFIC PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 163. ASIA-PACIFIC PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2023 (USD MILLION)
  • TABLE 164. ASIA-PACIFIC PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2024-2030 (USD MILLION)
  • TABLE 165. ASIA-PACIFIC PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 166. ASIA-PACIFIC PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 167. ASIA-PACIFIC PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2023 (USD MILLION)
  • TABLE 168. ASIA-PACIFIC PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2024-2030 (USD MILLION)
  • TABLE 169. ASIA-PACIFIC PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2023 (USD MILLION)
  • TABLE 170. ASIA-PACIFIC PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2024-2030 (USD MILLION)
  • TABLE 171. ASIA-PACIFIC PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 172. ASIA-PACIFIC PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 173. ASIA-PACIFIC PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 174. ASIA-PACIFIC PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 175. ASIA-PACIFIC PERSONALIZED MEDICINE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 176. ASIA-PACIFIC PERSONALIZED MEDICINE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 177. AUSTRALIA PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 178. AUSTRALIA PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 179. AUSTRALIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2023 (USD MILLION)
  • TABLE 180. AUSTRALIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2024-2030 (USD MILLION)
  • TABLE 181. AUSTRALIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 182. AUSTRALIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 183. AUSTRALIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2023 (USD MILLION)
  • TABLE 184. AUSTRALIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2024-2030 (USD MILLION)
  • TABLE 185. AUSTRALIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2023 (USD MILLION)
  • TABLE 186. AUSTRALIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2024-2030 (USD MILLION)
  • TABLE 187. AUSTRALIA PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 188. AUSTRALIA PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 189. AUSTRALIA PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 190. AUSTRALIA PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 191. CHINA PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 192. CHINA PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 193. CHINA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2023 (USD MILLION)
  • TABLE 194. CHINA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2024-2030 (USD MILLION)
  • TABLE 195. CHINA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 196. CHINA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 197. CHINA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2023 (USD MILLION)
  • TABLE 198. CHINA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2024-2030 (USD MILLION)
  • TABLE 199. CHINA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2023 (USD MILLION)
  • TABLE 200. CHINA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2024-2030 (USD MILLION)
  • TABLE 201. CHINA PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 202. CHINA PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 203. CHINA PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 204. CHINA PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 205. INDIA PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 206. INDIA PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 207. INDIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2023 (USD MILLION)
  • TABLE 208. INDIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2024-2030 (USD MILLION)
  • TABLE 209. INDIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 210. INDIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 211. INDIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2023 (USD MILLION)
  • TABLE 212. INDIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2024-2030 (USD MILLION)
  • TABLE 213. INDIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2023 (USD MILLION)
  • TABLE 214. INDIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2024-2030 (USD MILLION)
  • TABLE 215. INDIA PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 216. INDIA PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 217. INDIA PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 218. INDIA PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 219. INDONESIA PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 220. INDONESIA PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 221. INDONESIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2023 (USD MILLION)
  • TABLE 222. INDONESIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2024-2030 (USD MILLION)
  • TABLE 223. INDONESIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 224. INDONESIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 225. INDONESIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2023 (USD MILLION)
  • TABLE 226. INDONESIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2024-2030 (USD MILLION)
  • TABLE 227. INDONESIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2023 (USD MILLION)
  • TABLE 228. INDONESIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2024-2030 (USD MILLION)
  • TABLE 229. INDONESIA PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 230. INDONESIA PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 231. INDONESIA PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 232. INDONESIA PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 233. JAPAN PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 234. JAPAN PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 235. JAPAN PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2023 (USD MILLION)
  • TABLE 236. JAPAN PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2024-2030 (USD MILLION)
  • TABLE 237. JAPAN PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 238. JAPAN PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 239. JAPAN PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2023 (USD MILLION)
  • TABLE 240. JAPAN PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2024-2030 (USD MILLION)
  • TABLE 241. JAPAN PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2023 (USD MILLION)
  • TABLE 242. JAPAN PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2024-2030 (USD MILLION)
  • TABLE 243. JAPAN PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 244. JAPAN PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 245. JAPAN PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 246. JAPAN PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 247. MALAYSIA PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 248. MALAYSIA PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 249. MALAYSIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2023 (USD MILLION)
  • TABLE 250. MALAYSIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2024-2030 (USD MILLION)
  • TABLE 251. MALAYSIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 252. MALAYSIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 253. MALAYSIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2023 (USD MILLION)
  • TABLE 254. MALAYSIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2024-2030 (USD MILLION)
  • TABLE 255. MALAYSIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2023 (USD MILLION)
  • TABLE 256. MALAYSIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2024-2030 (USD MILLION)
  • TABLE 257. MALAYSIA PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 258. MALAYSIA PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 259. MALAYSIA PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 260. MALAYSIA PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 261. PHILIPPINES PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 262. PHILIPPINES PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 263. PHILIPPINES PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2023 (USD MILLION)
  • TABLE 264. PHILIPPINES PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2024-2030 (USD MILLION)
  • TABLE 265. PHILIPPINES PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 266. PHILIPPINES PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 267. PHILIPPINES PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2023 (USD MILLION)
  • TABLE 268. PHILIPPINES PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2024-2030 (USD MILLION)
  • TABLE 269. PHILIPPINES PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2023 (USD MILLION)
  • TABLE 270. PHILIPPINES PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2024-2030 (USD MILLION)
  • TABLE 271. PHILIPPINES PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 272. PHILIPPINES PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 273. PHILIPPINES PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 274. PHILIPPINES PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 275. SINGAPORE PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 276. SINGAPORE PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 277. SINGAPORE PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2023 (USD MILLION)
  • TABLE 278. SINGAPORE PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2024-2030 (USD MILLION)
  • TABLE 279. SINGAPORE PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 280. SINGAPORE PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 281. SINGAPORE PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2023 (USD MILLION)
  • TABLE 282. SINGAPORE PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2024-2030 (USD MILLION)
  • TABLE 283. SINGAPORE PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2023 (USD MILLION)
  • TABLE 284. SINGAPORE PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2024-2030 (USD MILLION)
  • TABLE 285. SINGAPORE PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 286. SINGAPORE PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 287. SINGAPORE PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 288. SINGAPORE PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 289. SOUTH KOREA PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 290. SOUTH KOREA PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 291. SOUTH KOREA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2023 (USD MILLION)
  • TABLE 292. SOUTH KOREA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2024-2030 (USD MILLION)
  • TABLE 293. SOUTH KOREA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 294. SOUTH KOREA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 295. SOUTH KOREA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2023 (USD MILLION)
  • TABLE 296. SOUTH KOREA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2024-2030 (USD MILLION)
  • TABLE 297. SOUTH KOREA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2023 (USD MILLION)
  • TABLE 298. SOUTH KOREA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2024-2030 (USD MILLION)
  • TABLE 299. SOUTH KOREA PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 300. SOUTH KOREA PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 301. SOUTH KOREA PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 302. SOUTH KOREA PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 303. TAIWAN PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 304. TAIWAN PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 305. TAIWAN PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2023 (USD MILLION)
  • TABLE 306. TAIWAN PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2024-2030 (USD MILLION)
  • TABLE 307. TAIWAN PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 308. TAIWAN PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 309. TAIWAN PERSONALIZED M